专题：Cancer-related cognitive impairment studies

This cluster of papers explores the mechanisms and impact of chemotherapy-induced cognitive impairment in cancer patients, particularly focusing on breast cancer survivors. It covers topics such as the neurobiological basis of cognitive dysfunction, the role of inflammatory cytokines, longitudinal assessment of cognitive changes, and the effects of adjuvant treatments on cognition.
最新文献
近5年高被引文献
Alzheimer’s Disease: Epidemiology and Clinical Progression

article Full Text OpenAlex 626 FWCI67.5381

The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease

article Full Text OpenAlex 601 FWCI68.8514

Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US

article Full Text OpenAlex 555 FWCI56.2576

Blood biomarkers for Alzheimer’s disease in clinical practice and trials

article Full Text OpenAlex 514 FWCI91.0569

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

article Full Text OpenAlex 490 FWCI55.5345

Biomarker Changes during 20 Years Preceding Alzheimer’s Disease

article Full Text OpenAlex 452 FWCI119.898

Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation

article Full Text OpenAlex 414 FWCI109.8181

Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older: a meta-analysis and systematic review of epidemiology studies.

article Full Text OpenAlex 397 FWCI49.2017

Management of common clinical problems experienced by survivors of cancer

article Full Text OpenAlex 324 FWCI21.4827

Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort

article Full Text OpenAlex 317 FWCI32.122